Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Lymphoma

Free Subscription 30.03.2026 1 Am J Hematol 3 Blood 1 BMC Cancer 2 Br J Haematol 1 Cancer 1 Eur J Haematol 1 J Am Acad Dermatol 1 J Natl Cancer Inst 5 Leuk Lymphoma 1 Leukemia

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. NOOR WD, Seymour JF, Cheah CY
   Marginal Zone Lymphoma: 2026 Update on Diagnosis and Management.
   Am J Hematol. 2026 Mar 23. doi: 10.1002/ajh.70289.
   PubMed         Abstract available
   
   

   
   Blood

2. 
   Ronceray L, Huibers MHW, Reutter K, et al. High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition. Blood. 2026;147(2):209-214.
   Blood. 2026;147:1504.
   PubMed        
   
   
3. 
   Jaye DL, Feldman AL. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma. Blood. 2023;141(17):2160.
   Blood. 2026;147:1504.
   PubMed        
   
   
4. KAMDAR M, Bartlett NL
   From Breakthroughs to Blueprints: Evolving Evidence and Future Directions in Relapsed and Refractory Large B-Cell Lymphoma.
   Blood. 2026 Mar 23:blood.2025030859. doi: 10.1182/blood.2025030859.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. JANG HC, Song GY, Kang SR, Han SJ, et al
   High-risk subgroup and associated genes identified by next generation sequencing in diffuse large B cell lymphoma.
   BMC Cancer. 2026 Mar 23. doi: 10.1186/s12885-026-15868.
   PubMed        
   
   

   
   Br J Haematol

6. LUAN M, Jia R, Wang D, Zhang F, et al
   Early prediction of adult lymphoma-associated haemophagocytic lymphohistiocytosis using an interpretable machine learning model.
   Br J Haematol. 2026 Mar 23. doi: 10.1111/bjh.70447.
   PubMed         Abstract available
   
   
7. CLIFF ERS, McKeague S, Dickinson MJ
   Choosing between Nivo-AVD and BrECADD: Hodgkin lymphoma's new era.
   Br J Haematol. 2026 Mar 23. doi: 10.1111/bjh.70451.
   PubMed        
   
   

   
   Cancer

8. GAO Y, Jiang M, Zhang X, Liu L, et al
   Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment-naive peripheral T-cell lymphoma: A multicenter, open-label, single-arm, phase 1b trial.
   Cancer. 2026;132:e70360.
   PubMed         Abstract available
   
   

   
   Eur J Haematol

9. GARCIA CR, Campuzano DM, Ruiz ABG, Moreno ES, et al
   Intravascular Large B-Cell Lymphoma: Clinicopathological Characteristics and Outcomes.
   Eur J Haematol. 2026 Mar 23. doi: 10.1111/ejh.70170.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

10. BALAN K, Lallas A, Akdogan N
    Patterns and Pitfalls: Dermoscopic Differentiation of Early-Stage Mycosis Fungoides, Atopic Dermatitis, and Psoriasis.
    J Am Acad Dermatol. 2025 Dec 17:S0190-9622(25)03431.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

11. GEURTS YM, Neppelenbroek SIM, Aleman BMP, Janus CPM, et al
    Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma.
    J Natl Cancer Inst. 2026 Mar 25:djag085. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

12. JORGENSEN JB, Hansen KV, Nielsen LK, Gade IL, et al
    First-line immunochemotherapy for indolent lymphoma does not affect muscle volume: a post hoc analysis of 472 patients in long-term remissions from the GALLIUM study.
    Leuk Lymphoma. 2026 Mar 25:1-10. doi: 10.1080/10428194.2026.2642931.
    PubMed         Abstract available
    
    
13. KIM DH, Cha S, Koh Y, Byun JM, et al
    Allogeneic hematopoietic stem cell transplantation following T-cell-directed immunotherapy failure in B-cell lymphoma: a real-world case series and systematic literature review.
    Leuk Lymphoma. 2026 Mar 22:1-10. doi: 10.1080/10428194.2026.2638438.
    PubMed         Abstract available
    
    
14. WALTER C, Burger MC, Siebenbrodt K, Mooshage CM, et al
    Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma.
    Leuk Lymphoma. 2026 Mar 22:1-5. doi: 10.1080/10428194.2026.2647957.
    PubMed        
    
    
15. GONG IY, Kuruvilla J
    Management of relapsed/refractory DLBCL in the era of novel agents and new approaches.
    Leuk Lymphoma. 2026;67:756-784.
    PubMed         Abstract available
    
    
16. KLEBANER D, Park NJ, Marar M, Frank M, et al
    Treatment kinetics and local response during and after bridging radiotherapy prior to CAR-T cell therapy for lymphomas.
    Leuk Lymphoma. 2026;67:813-820.
    PubMed         Abstract available
    
    

    
    Leukemia

17. YANG Y, Tang Z, Hu Q, Yang P, et al
    Targeting UHRF1 induces regression of aggressive mantle cell lymphoma.
    Leukemia. 2026 Mar 24. doi: 10.1038/s41375-026-02915.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum